SCHEMBL29372174

SCHEMBL29372174

Cn1c(=O)cc(-c2cccc(Cl)c2)c2ccccc21

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.72
FNTA P49354 7/20 0.54
FNTB P49356 7/20 0.54
KDM4E B2RXH2 1/20 0.51
NQO2 P16083 1/20 0.51
KMT2A Q03164 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
ALDH1A1 P00352 1/20 0.46
PARP1 P09874 1/20 0.45
BRD4 O60885 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
PGR P06401 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7209358 1.00 HSD17B10 (0.72) HSD17B10FNTAFNTBKDM4ENQO2
SCHEMBL27433966 0.84 HSD17B10 (1.00) HSD17B10KDM4ENQO2KMT2ALMNA
SCHEMBL8179893 0.83 CA12 (0.54) HSD17B10FNTAFNTBPGR
SCHEMBL6010441 0.83 FNTA (0.57) HSD17B10FNTAFNTBKMT2APGR
SCHEMBL8171779 0.83 FNTA (0.55) HSD17B10FNTAFNTB
SCHEMBL27519041 0.82 FNTA (0.49) HSD17B10FNTAFNTBPGR
SCHEMBL7088593 0.82 FNTA (0.56) HSD17B10FNTAFNTBCYP3A4
SCHEMBL8185670 0.81 EGFR (0.50) HSD17B10FNTAFNTBKDM4EHPGD
SCHEMBL8171501 0.81 FNTA (0.53) HSD17B10FNTAFNTBKDM4EKMT2A
SCHEMBL24095575 0.81 HSD17B10 (0.69) HSD17B10FNTAFNTBKDM4ENQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115504933-B Preparation method and application of polysubstituted quinolinone compound 深圳万知达企业管理有限公司 2024-12-13 CN disclosed
WO-2023141082-A1 SOLID STATE FORMS OF TIPIFARNIB AND PROCESS FOR PREPARATION THEREOF TEVA CZECH INDUSTRIES S.R.O. (CZ) 2023-07-27 WO disclosed
CN-112424149-B Synthesis of tipifanib 库拉肿瘤学公司 2023-06-23 CN disclosed
CN-115504933-A Preparation method and application of polysubstituted quinolinone compound 广东工业大学 2022-12-23 CN disclosed
CN-114761006-A Methods of treating cancer resistant to kinase inhibitors INSERM(法国国家健康医学研究院) 2022-07-15 CN disclosed
CN-108289922-B Therapeutic methods and compositions for treating non-small cell lung cancer 友杏生技医药股份有限公司 2022-02-08 CN disclosed